Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
CVD Risk Assessment and Diagnosis in HIV Infection
Faculty
Michael S. Lloyd, MD
Emory University
Atlanta, GA
Accredited by
American Heart Association
Activity Details
| Credit Types: | CME / CE |
| Release Date: | 2011-May-26 |
| Expiration Date: | 2012-Nov-03 |
| Estimated Time for Completion: | 1 hour |
| Registration Required: | No |
| Cost: | Free |
Part 2 of a 3-Part series
Part 1: Overview of CVD and HIV Infection
Part 3: CVD Risk Management in HIV Infection
Jointly sponsored by the American Academy of HIV Medicine.
Target Audience
- Cardiologists
- Endocrinologists
- Infectious disease practitioners
- HIV treaters
- Internal medicine practitioners
- Family practitioners
- Nurses
- Other primary care physicians
Description
Michael S. Lloyd, MD will present on CVD Risk Assessment and Diagnosis in HIV infection. Dr. Lloyd is a board certified internist, cardiologist and electrophysiologist. Dr. Lloyd will discuss how to assess CVD risk in HIV-infected individuals, apply conventional CHD diagnostic techniques in HIV-infected individuals and recognize the potential role of newer diagnostic techniques for the earlier detection of CHD.
Learning Objectives:
At the completion of this online course, the learner will be able to:
- Assess CVD risk in HIV-infected individuals.
- Apply conventional CHD diagnostic techniques in HIV-infected individuals.
- Recognize the potential role of newer diagnostics techniques for the earlier detection of CHD.
Course Agenda
| Segment | Speaker |
| Pre-test | |
| CVD Risk Assessment and Diagnosis in HIV Infection | Michael S. Lloyd, MD |
| Post-test | |
| Post-test results | |
| Evaluation |
Faculty
Michael S. Lloyd, MD
Emory University
Accreditation Statements:
Continuing Medical Education Accreditation - Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Heart Association and the American Academy of HIV Medicine. The American Heart Association is accredited by the ACCME to provide continuing medical education for physicians.
The American Heart Association designates this educational activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
All faculty participating in CME/CE activities sponsored by The American Heart Association will disclose to the audience (1) significant financial relationships with the manufacturer(s) of products from the commercial supporter(s) and/or the manufacturer(s) of products or devices discussed in their presentation, and (2) unlabeled/unapproved uses of drugs or devices discussed in their presentation. Such disclosures will be made in writing in course presentation materials.
AAFP Credit
This activity, Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living with HIV/AIDS Web Course, has been reviewed and is acceptable for up to 3 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins December 14, 2009. Term of approval is for two years from this date. Each web course is approved for 1 Prescribed credit.
Continuing Medical Education Accreditation – Physician Assistants
AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 CreditTM from organizations accredited by ACCME.
Continuing Education Accreditation - Nurses
The American Heart Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
The maximum number of hours awarded for this CE activity is 0.75 contact hours.
ORIGINAL RELEASE DATE: December 28, 2010
TERMINATION DATE: November 3, 2012
LAST REVIEW DATE: November 3, 2009
ACCREDITATION TERMS:
- ACCME/AMA (Physicians) – December 2, 2009 – November 3, 2012
- ANCC (Nurses) – December 2, 2010 – November 3, 2012
Disclosures
| Faculty Member | Employment | Research Grant | Consultant/ Advisory Board |
Stock Shareholder (directly purchased) | Honoraria | Other |
| Robert H. Eckel, MD | University of Colorado Denver School of Medicine | None | None | None | None | None |
| Carl J. Fichtenbaum, MD | University of Cincinnati College of Medicine | Tibotec Inc. (Johnson & Johnson) | None | None | None | Pfizer & Progenics (funding to conduct clinical trial), Abbott Laboratories (funding for investigator initiated project) |
| C. Bradley Hare, MD | UCSF San Francisco General Hospital | None | GSK, Pfizer, Tibotec, Merck, Abbott, BMS, Gilead, Roche, Schering, Monogram Biosciences | None | GSK, Pfizer, Tibotec, Merck, Abbott, BMS, Gilead, Roche, Schering, Monogram Biosciences | Speaker for the following: GSK, Merck, Abbott, BMS, Gilead, Roche |
| Priscilla Hsue, MD | UCSF San Francisco General Hospital | None | None | None | None | None |
| Jeffrey T. Kirchner, DO, FAAFP, AAHIVS | Lancaster General Hospital | None | BMS Speakers Bureau (not spoken on BMS' behalf this yr. signed to potentially do so until 12/09) | None | None | Prog. receives federal funding Ryan White Care Act. Dept. of Health and Human Svcs/HIV AIDS Bureau |
| Lisa Kosmiski, MD | University of Colorado Denver Health Sciences Center | None | None | None | None | None |
| Ken A. Lichtenstein, MD | HIV Clinical and Research Program National Jewish Health | Merck, Pfizer, TaiMed | Merck, BMS, Gilead, GSK | None | None | Speaker: Gilead, BMS, Merck |
| Steven E. Lipshultz, MD | University of Miami Miller School of Medicine |
NIH (NCI) | None | None | None | Other Research support: Lance Armstrong Foundation, Women's Cancer Association, Chiron Corporation Ltd., Pharmacia & Upjohn-A Pfizer Company, Roche Diagnostics Corporation, Singulex, Inc. |
| Michael S. Lloyd, MD | Emory University | None | None | None | None | None |
| Anne Luetkemeyer, MD | UCSF San Francisco General Hospital | None | None | None | None | None |
| Kathryn A. Taubert, PhD, FAHA | AHA | None | None | None | None | None |
| This table represents the relationships of the activity CVD Risk Assessment and Diagnosis in HIV Infection faculty members that may be perceived as actual or reasonable perceived conflicts of interest as reported on the Disclosure Questionnaire which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content. | ||||||
Medium
This activity is an online video.
Participation and Successful Completion
Successful completion of this CE activity includes the following: (1) Register and view the course online. (2) Take the activity Post test (3) Complete the evaluation survey (4) Print your CME/CE Certificate from your own printer. There is no fee for CME/CE credits for this activity. The link to the CME/CE “Professional Education Center” website can also be found on www.my.americanheart.org.
System Requirements
A high speed internet connection with a minimum speed of 1 Mb/second is recommended.
Contact Information
For activity information, please contact the American Heart Association at 888-242-2453. For any technical issues, please contact info@opencme.org
Discussion
Discuss this course with your colleagues on our Professional Online Network’s forums.
Grant Support
Supported by an educational grant from 
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
